Actively Recruiting
Myeloproliferative Neoplasms (MPNs) Patient Registry
Led by University Health Network, Toronto · Updated on 2024-08-27
5000
Participants Needed
1
Research Sites
656 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The mandate of this MPN registry is to collect clinical information, including molecular results, from consenting patients with a variety of MPNs at different time points during the course of their disease.
CONDITIONS
Official Title
Myeloproliferative Neoplasms (MPNs) Patient Registry
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Diagnosis of one of the following myeloproliferative neoplasms (MPNs): Atypical CML (aCML)
- Chronic eosinophilic leukemia-not otherwise specified (CEL, NOS)
- Chronic myelomonocytic leukemia (CMML)
- Chronic neutrophilic leukemia (CNL)
- Essential thrombocythemia (ET)
- Juvenile myelomonocytic leukemia (JMML)
- Mastocytosis, MPN unclassifiable
- MPN/MDS unclassifiable
- Primary myelofibrosis (PMF)
- Post-essential thrombocythemia myelofibrosis (post-ET MF)
- Post-polycythemia vera MF (post-PV MF)
- Refractory anemia with ringed sideroblasts associated with marked thrombocytosis (RARS-T)
You will not qualify if you...
History of severe allergic reactions to study medication Currently pregnant or breastfeeding Recent participation in another clinical trial within the last 30 days Presence of uncontrolled medical conditions that could affect safety
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Princess Margaret Cancer Centre
Toronto, Ontario, Canada, M5G 1Z5
Actively Recruiting
Research Team
V
Vikas Gupta, MD
CONTACT
J
Jaime O. Claudio, PhD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here